An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Figure 1
Extracellular nucleotide release and signalling…
Figure 1
Extracellular nucleotide release and signalling during inflammation. During inflammation, multiple cell types release…
Figure 1
Extracellular nucleotide release and signalling during inflammation. During inflammation, multiple cell types release nucleotides, for example ATP or ADP, from their intracellular compartments into the extracellular space. Nucleotides can be released during mechanical injury, necrosis, apoptosis or inflammatory cell activation. Several molecular pathways have been implicated in this process, such as vesicular ADP release from platelets, pannexin-mediated ATP release during apoptosis, and connexin- or pannexin-mediated ATP release from inflammatory cells, such as neutrophils. Extracellular nucleotides function as signalling molecules through the activation of purinergic P2 receptors. These receptors can be grouped into metabotropic P2Y receptors (P2YRs; GPCRs with seven transmembrane-spanning motifs) or ionotropic P2X receptors (P2XRs), which are nucleotide-gated ion channels. Each P2XR is formed by three subunits (P2XR monomers), each of which consists of two transmembrane regions, TM1 and TM2. Binding of three molecules of ATP to the assembled P2X channel causes opening of a central pore. These conformational changes allow for flux of ions such as sodium (Na+), calcium (Ca2+) and potassium (K+) across the membrane. ATP signalling is terminated by the enzymatic conversion of ATP to adenosine through the ectonucleoside triphosphate diphosphohydrolase CD39 (conversion of ATP/ADP to AMP) and the ecto-5′-nucleotidase CD73 (conversion of AMP to adenosine). Similar to ATP, adenosine (A) functions as an extracellular signalling molecule through the activation of purinergic P1 adenosine receptors. Material from: Idzko et al. (1). Reprinted with permission.
Editorial on the Research Topic Purinergic Signaling and Inflammation
References
Idzko M, Ferrari D, Eltzschig HK. Nucleotide Signalling During Inflammation. Nature (2014) 509:310–7. 10.1038/nature13085
-
DOI
-
PMC
-
PubMed
Poth JM, Brodsky K, Ehrentraut H, Grenz A, Eltzschig HK. Transcriptional Control of Adenosine Signaling by Hypoxia-Inducible Transcription Factors During Ischemic or Inflammatory Disease. J Mol Med (Berl) (2013) 91:183–93. 10.1007/s00109-012-0988-7
-
DOI
-
PMC
-
PubMed
Yuan X, Lee JW, Bowser JL, Neudecker V, Sridhar S, Eltzschig HK. Targeting Hypoxia Signaling for Perioperative Organ Injury. Anesth Analg (2018) 126:308–21. 10.1213/ANE.0000000000002288
-
DOI
-
PMC
-
PubMed
Millien VO, Lu W, Mak G, Yuan X, Knight JM, Porter P, et al. . Airway Fibrinogenolysis and the Initiation of Allergic Inflammation. Ann Am Thorac Soc (2014) 11(Suppl 5):S277–83. 10.1513/AnnalsATS.201403-105AW
-
DOI
-
PMC
-
PubMed
Le TT, Berg NK, Harting MT, Li X, Eltzschig HK, Yuan X. Purinergic Signaling in Pulmonary Inflammation. Front Immunol (2019) 10:1633. 10.3389/fimmu.2019.01633
-
DOI
-
PMC
-
PubMed